Novartis Ag (NVSEF) Enterprise Value Growth (3y) (2017 - 2026)

Novartis Ag (NVSEF) Enterprise Value Growth (3y) (2017 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Novartis Ag - - -

Historic Data

Download Data
DateValue
Mar 31, 2026 27.28%
Dec 31, 2025 47.53%
Sep 30, 2025 -30.82%
Jun 30, 2025 24.43%
Mar 31, 2025 -22.92%
Dec 31, 2024 57.08%
Sep 30, 2024 12.36%
Jun 30, 2024 -225.32%
Mar 31, 2024 -1,821.37%
Dec 31, 2023 -7.66%
Sep 30, 2023 -131.10%
Jun 30, 2023 -191.31%
Mar 31, 2023 20.68%
Dec 31, 2022 -18.26%
Sep 30, 2022 36.21%
Jun 30, 2022 -28.52%
Mar 31, 2022 55.68%
Dec 31, 2021 -22.64%
Sep 30, 2021 -10.62%
Jun 30, 2021 73.49%